Accelerate@Babraham 2025 Announces New Cohort
The Accelerate@Babraham 2025 cohort Pictured: Back row (Left to right) Lucy Rowbotham (Sysora Health), Vivian Wong (MabGalaxy), Andy Wood (MabGalaxy), Kevin Chalut (Cycle Therapeutics), Jenny Hirst (Programme Manager, Accelerate@Babraham) Front row (Left to right)...
Babraham Research Campus’ £3.15bn Life Science Ecosystem Soars
New report reveals how groundbreaking research at the Campus is delivering major gains for UK economic growth and job creation A new independent report evaluating the economic and scientific impact of the Babraham Research Campus has revealed significant contributions...
Babraham Research Campus Ltd appoints Dr Louise Jopling as Chief Scientific & Innovation Officer
Babraham Research Campus Ltd, which is responsible for the development and management of Babraham Research Campus is delighted to announce the appointment of Dr Louise Jopling to the newly created role of Chief Scientific & Innovation Officer. Louise has almost 30...
Accelerate@Babraham selects its next set of science superstars!
Pictured: from left, Krishnaa Mahbubani (The New Platelet Company), Marloes Tijssen (The New Platelet Company), Lavenniah Annadoray (Ephyra), Jess Stokes (enstic), Programme Manager Jenny Hirst, Staša Stanković (OvartiX), Alexandre Webster (U-Ploid biotechnologies...
PlaqueTec and the Babraham Institute collaborate on early phase target discovery and development
PlaqueTec, a company identifying endotype-specific biomarkers to advance precision medicine for coronary artery disease (CAD), based at the Babraham Research Campus, and the Welch research group at the Babraham Institute today announced the successful completion of a...
